Cargando…

Frequency of EBV associated classical Hodgkin lymphoma decreases over a 54-year period in a Brazilian population

The epidemiology of classical Hodgkin lymphoma varies significantly in populations with different socioeconomic conditions. Among other changes, improvement in such conditions leads to a reduction in the association with EBV infection and predominance of the nodular sclerosis subtype. This study pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campos, Antonio Hugo Jose Froes Marques, Moreira, Adriana, Ribeiro, Karina Braga, Paes, Roberto Pinto, Zerbini, Maria Claudia, Aldred, Vera, de Souza, Carmino Antonio, Neto, Cristovam Scapulatempo, Soares, Fernando Augusto, Vassallo, Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789833/ https://www.ncbi.nlm.nih.gov/pubmed/29382865 http://dx.doi.org/10.1038/s41598-018-20133-6

Ejemplares similares

A microRNA signature profile in EBV(+) diffuse large B-cell lymphoma of the elderly
por: de Andrade, Tathiana Azevedo, et al.
Publicado: (2014)

HLA Associations in Classical Hodgkin Lymphoma: EBV Status Matters
por: Huang, Xin, et al.
Publicado: (2012)

Matrix Metalloproteinase-9 Expression by Hodgkin-Reed-Sternberg Cells Is Associated with Reduced Overall Survival in Young Adult Patients with Classical Hodgkin Lymphoma
por: Campos, Antonio Hugo, et al.
Publicado: (2013)

Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
por: Biasoli, Irene, et al.
Publicado: (2023)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

Mutational Profile of Driver Genes in Brazilian Melanomas
por: Vicente, Anna Luiza S.A., et al.
Publicado: (2019)

Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma
por: Bond, David A., et al.
Publicado: (2019)

HLA-A*02:07 Is a Protective Allele for EBV Negative and a Susceptibility Allele for EBV Positive Classical Hodgkin Lymphoma in China
por: Huang, Xin, et al.
Publicado: (2012)

Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas
por: Mundo, Lucia, et al.
Publicado: (2020)

Changes in EBV Association Pattern in Pediatric Classic Hodgkin Lymphoma From a Single Institution in Argentina
por: De Matteo, Elena, et al.
Publicado: (2019)

Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group
por: Cerci, Juliano Júlio, et al.
Publicado: (2018)

Correction: Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas
por: Mundo, Lucia, et al.
Publicado: (2020)

Role of Genetic Ancestry in 1,002 Brazilian Colorectal Cancer Patients From Barretos Cancer Hospital
por: Durães, Ronilson Oliveira, et al.
Publicado: (2020)

P018: Treatment outcomes in classical Hodgkin lymphoma (HL): 5-year update report from the Brazilian Prospective Registry
por: Biasoli, Irene, et al.
Publicado: (2022)

Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma
por: Jiang, Peijia, et al.
Publicado: (2022)

Follicular dendritic cells display microvesicle-associated LMP1 in reactive germinal centers of EBV+ classic Hodgkin lymphoma
por: Uccini, Stefania, et al.
Publicado: (2019)

PD-L1 and EBV LMP1 expressions in classic Hodgkin lymphomas and its correlation with clinicopathological parameters and prognosis
por: ÖZDEMİR, Süleyman, et al.
Publicado: (2022)

Composite Lymphoma with Follicular Lymphoma Transformation to Clonally Related Epstein–Barr Virus (EBV) Positive Diffuse Large B-Cell Lymphoma and EBV-PositiveClassic Hodgkin Lymphoma
por: Ryder, Christopher B., et al.
Publicado: (2023)

EBV in situ hybridization study for non-Hodgkin's lymphomas.
por: Ko, Y. H., et al.
Publicado: (1994)

Cervicovaginal cytology in patients undergoing pelvic radiotherapy using the Focalpoint system: results from the RODEO study
por: Stein, Maíra Degiovani, et al.
Publicado: (2015)

Role of ADAM10 as a CD30 Sheddase in Classical Hodgkin Lymphoma
por: Hansen, Hinrich P., et al.
Publicado: (2020)

The role of TMPRSS2:ERG in molecular stratification of PCa and its association with tumor aggressiveness: a study in Brazilian patients
por: Eguchi, Flávia C., et al.
Publicado: (2014)

EBV-associated recurrent Hodgkin's disease after renal transplantation
por: Flanagan, Katherine H, et al.
Publicado: (2006)

Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents
por: Alexander, F E, et al.
Publicado: (2000)

HHV8-positive, EBV-positive Hodgkin lymphoma-like large B cell lymphoma: expanding the spectrum of HHV8 and EBV-associated lymphoproliferative disorders
por: Sanchez, Sandra, et al.
Publicado: (2020)

Chronic myeloid leukemia treatment guidelines: Brazilian Association of Hematology, Hemotherapy and Cell Therapy. Brazilian Medical Association Guidelines Project - 2012
por: de Souza, Carmino Antonio, et al.
Publicado: (2012)

Profile of esophageal squamous cell carcinoma mutations in Brazilian patients
por: Munari, Fernanda Franco, et al.
Publicado: (2021)

Genetics of classical Hodgkin Lymphoma
por: Schiavoni, Gianluca, et al.
Publicado: (2018)

Advantage of HSP110 (T17) marker inclusion for microsatellite instability (MSI) detection in colorectal cancer patients
por: Berardinelli, Gustavo Noriz, et al.
Publicado: (2018)

Aberrant Expression of ID2 protein and its correlation with EBV-LMP1 and P16(INK4A) in Classical Hodgkin Lymphoma in China
por: Zhao, Po, et al.
Publicado: (2008)

HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02
por: Martín, Paloma, et al.
Publicado: (2015)

Everolimus as a single agent in refractory or relapsed Hodgkin's lymphoma: the Brazilian Named Patient Program Experience
por: Rocha, Talita Máira Bueno da Silveira da, et al.
Publicado: (2017)

The impact of HLA class I and EBV latency‐II antigen‐specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma
por: Jones, K., et al.
Publicado: (2015)

Genetic alterations detected by comparative genomic hybridization in BRCAX breast and ovarian cancers of Brazilian population
por: Felicio, Paula Silva, et al.
Publicado: (2018)

The EBV action in tonsils and adenoids
por: Endo, L.H., et al.
Publicado: (2003)

Seasonal differences in the onset of the EBV-positive and -negative forms of paediatric Hodgkin's lymphoma
por: Reiman, A, et al.
Publicado: (2003)

Reduced frequency of cytotoxic CD56(dim) CD16(+) NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma
por: Pánisová, Elena, et al.
Publicado: (2021)

The molecular mechanisms of classic Hodgkin's lymphoma.
por: Felberbaum, Rachael S.
Publicado: (2005)

Immunological Deregulation in Classic Hodgkin Lymphoma
por: Romano, Alessandra, et al.
Publicado: (2014)

Controversies in the Treatment of Classical Hodgkin Lymphoma
por: Eichenauer, Dennis A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_332u6jj6gmef9citdta46m48j5